Evaluation of Platelet Function After Statin Loading Dose in Patients Before Percutaneous Coronary Intervention - Trial NCT01526460
Access comprehensive clinical trial information for NCT01526460 through Pure Global AI's free database. This Phase 2 trial is sponsored by IRCCS San Raffaele and is currently Completed. The study focuses on Platelet Dysfunction. Target enrollment is 146 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
IRCCS San Raffaele
Timeline & Enrollment
Phase 2
Aug 01, 2011
Feb 01, 2014
Primary Outcome
Area Under the Aggregation Curve (AUC) measured with the Multiplate 5.0 Analyzer
Summary
The purpose of this study is to evaluate the effect of a loading dose of two different
 statins on platelet reactivity (atorvastatin, metabolized by CYP3A4, and rosuvastatin, which
 is rather independent of this enzyme)in patients at least 5 days in therapy with aspirin and
 clopidogrel (with or without an undergoing treatment with statins) undergoing PCI for
 coronary disease with chronic stable angina and/or evidence of inducible myocardial ischemia.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT01526460
Non-Device Trial